Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00788_DB08814> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00788_DB08814 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00788_DB08814 label "DDI between Naproxen and Triflusal - The metabolite of triflusal, 2-hydroxy-4-trifluoro-methyl-benzoic acid (HTB), impairs the serum protein binding of naproxen to the same extent as acetylsalisylic acid. Thus, the free fraction of glisentide may be increased. A dosage reduction may be required if used in combination. [drugbank_resource:DB00788_DB08814]" assertion.
- drugbank_resource:DB00788_DB08814 identifier "drugbank_resource:DB00788_DB08814" assertion.
- drugbank_resource:DB00788_DB08814 title "DDI between Naproxen and Triflusal - The metabolite of triflusal, 2-hydroxy-4-trifluoro-methyl-benzoic acid (HTB), impairs the serum protein binding of naproxen to the same extent as acetylsalisylic acid. Thus, the free fraction of glisentide may be increased. A dosage reduction may be required if used in combination." assertion.